Genotypic analysis of varicella-zoster virus and its seroprevalence in Finland

Clinical and Vaccine Immunology

Volumn 14, Issue 9, 2007, Pages 1057-1061

  Koskiniemi, Marjaleena ^a   Lappalainen, Maija ^b   Schmid, D Scott ^c   Rubtcova, Elena ^c   Loparev, Vladimir N ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d Centers for Disease Control and Prevention   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; DATA ANALYSIS; FINLAND; GENOTYPE; GROUPS BY AGE; HERPES ZOSTER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROPREVALENCE; VARICELLA ZOSTER VIRUS; VIRUS STRAIN;

ADOLESCENT; ADULT; CHICKENPOX; CHILD; CHILD, PRESCHOOL; FEMALE; FINLAND; GENOTYPE; HERPESVIRUS 3, HUMAN; HUMANS; INFANT; INFANT, NEWBORN; MALE; SEROEPIDEMIOLOGIC STUDIES;

EID: 34948855501     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00348-06     Document Type: Article

References (37)

1. Argaw, T., J. I. Cohen, M. Klutch, K. Lekstrom, T. Yoshikawa, Y. Asano, and P. R. Krause. 2000. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates. J. Infect. Dis. 181:1153-1157.
2. Arvin, A. M. 1996. Varicella-zoster virus. Clin. Microbiol. Rev. 9:361-381.
3. Barrett-Muir, W., K. Hawrami, J. Clarke, and J. Breuer. 2001. Investigation of varicella-zoster virus variation by heteroduplex mobility assay. Arch. Virol. Suppl. 17:17-25.
4. Barrett-Muir, W., F. T. Scott, P. Aaby, J. John, P. Matondo, Q. L. Chaudhry, M. Siqueira, A. Poulsen, K. Yaminishi, and J. Breuer. 2003. Genetic variation of varicella-zoster virus: evidence for geographical separation of strains. J. Med. Virol. 70(Suppl. 1):S42-S47.
5. Campsall, P. A., N. H. Au, J. S. Prendiville, D. P. Speert, R. Tan, and E. E. Thomas. 2004. Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR. J. Clin. Microbiol. 42:1409-1413.
6. Carr, M. J., G. P. McCormack, and B. Crowley. 2004. Genetic variation in clinical varicella-zoster virus isolates collected in Ireland between 2002 and 2003. J. Med. Virol. 73:131-136.
7. Choo, P. W., J. G. Donahue, J. E. Manson, and R. Platt. 1995. The epidemiology of varicella and its complications. J. Infect. Dis. 172:706-712.
8. Chow, V. T., S. S. Wan, S. Doraisingham, and A. E. Ling. 1993. Comparative analysis of the restriction endonuclease profiles of the Dumas and Singapore strains of varicella-zoster virus. J. Med. Virol. 40:339-342.
9. Dayan, G. H., M. S. Panero, R. Debbag, A. Urquiza, M. Molina, S. Prieto, M. Del Carmen Perego, G. Scagliotti, D. Galimberti, G. Carroll, C. Wolff, D. S. Schmid, V. Loparev, D. Guris, and J. Seward. 2004. Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002. J. Clin. Microbiol. 42:5698-5704.
10. Dumas, A. M., J. L. Geelen, M. W. Weststrate, P. Wertheim, and J. van der Noordaa. 1981. XbaI, PstI, and BglII restriction enzyme maps of the two orientations of the varicella-zoster virus genome. J. Virol. 39:390-400.
11. Echevarria, J. M., I. Casas, and P. Martinez-Martin. 1997. Infections of the nervous system caused by varicella-zoster virus: a review. Intervirology 40:72-84.
12. Fleisher, G., W. Henry, M. McSorley, A. Arbeter, and S. Plotkin. 1981. Life threatening complications of varicella. Am. J. Dis. Child. 135:896-899.
13. Gilden, D. H., B. R. Beinlich, E. M. Rubinstein, E. Stommel, R. Swenson, D. Rubinstein, and D. Mahalingam. 1994. Varicella-zoster virus myelitis: an expanding spectrum. Neurology 44:1818-1823.
14. Gilden, D. H., B. K. Kleinschmidt-DeMasters, J. J. LaGuardia, R. Mahalingam, and R. J. Cohrs. 2000. Neurologic complications of the reactivation of varicella-zoster virus. N. Engl. J. Med. 342:635-645.
15. Gilden, D. H., R. R. Wright, S. A. Schneck, J. M. Gwaltney, Jr., and R. Mahalingam. 1994. Zoster sine herpete, a clinical variant. Ann. Neurol. 35:530-533.
16. Hawrami, K., and J. Breuer. 1997. Analysis of United Kingdom wild-type strains of varicella-zoster virus: differentiation from the Oka vaccine strain. J. Med. Virol. 53:60-62.
17. Heisler, M. B., and J. B. Richmond. 1994. Lessons from Finland's successful immunization program. N. Engl. J. Med. 331:1446-1447.
18. Koskiniemi, M., T. Rantalaiho, H. Piiparinen, C.-H. von Bonsdorff, M. Färkkilä, A. Järvinen, E. Kinnunen, S. Koskiniemi, L. Mannonen, M. Muttilainen, K. Linnavuori, J. Porras, M. Puolakkainen, K. Räihä, E.-M. Salonen, P. Ukkonen, A. Vaheri, V. Valtonen, et al. 2001. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J. Neurovirol. 7:400-408.
19. Koskiniemi, M., J. Rautonen, E. Lehtokoski-Lehtiniemi, and A. Vaheri. 1991. Epidemiology of encephalitis in children: a 20-year survey. Ann. Neurol. 29:492-497.
20. Koskiniemi, M., and A. Vaheri. 1989. Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children. Lancet i:31-34.
21. Kudesia, G., S. Partridge, C. P. Farrington, and N. Soltanpoor. 2002. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy. J. Clin. Pathol. 55:154-155.
22. Kupila, L., T. Vuorinen, R. Vainionpaa, V. Hukkanen, R. Marttila, and P. Kotilainen. 2006. Etiology of aseptic meningitis and encephalitis in an adult population. Neurology 66:75-80.
23. LaRussa, P., O. Lungu, I. Hardy, A. Gershon, S. P. Steinberg, and S. Silverstein. 1992. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J. Virol. 66:1016-1020.
24. LaRussa, P., S. Steinberg, A. Arvin, D. Dwyer, M. Burgess, M. Menegus, K. Rekrut, K. Yamanishi, and A. Gershon. 1998. Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world. J. Infect. Dis. 178(Suppl. 1):S64-S66.
25. Law, B., N. MacDonald, S. Halperin, D. Scheifele, P. Dery, T. Jadavji, M. H. Lebel, E. Mills, R. Morris, W. Vaudry, R. Gold, V. Marchessault, and P. Duclos. 2000. The Immunization Monitoring Program Active (IMPACT) prospective five year study of Canadian children hospitalized for chickenpox or associated complications. Pediatr. Infect. Dis. J. 19:1053-1059.
26. Lee, B. W. 1998. Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop. Med. Int. Health 3:886-890.
27. Lolekha, S., W. Tanthiphabha, P. Sornchai, P. Kosuwan, S. Sutra, B. Warachit, S. Chup-Upprakarn, Y. Hutagalung, J. Weil, and H. L. Bock. 2001. Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am. J. Trop. Med. Hyg. 64:131-136.
28. Loparev, V. N., T. Argaw, P. R. Krause, M. Takayama, and D. S. Schmid. 2000. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J. Clin. Microbiol. 38:3156-3160.
29. Loparev, V. N., A. Gonzalez, M. Deleon-Carnes, G. Tipples, H. Fickenscher, E. G. Torfason, and D. S. Schmid. 2004. Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J. Virol. 78:8349-8358.
30. Loparev, V. N., K. McCaustland, B. P. Holloway, P. R. Krause, M. Takayama, and D. S. Schmid. 2000. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J. Clin. Microbiol. 38:4315-4319.
31. Muir, W. B., R. Nichols, and J. Breuer. 2002. Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J. Virol. 76:1971-1979.
32. Mustonen, K., P. Mustakangas, M. Smeds, L. Mannonen, L. Uotila, A. Vaheri, and M. Koskiniemi. 1998. Antibodies to varicella zoster virus in the cerebrospinal fluid of neonates with seizures. Arch. Dis. Child. Fetal Neonatal Ed. 78:F57-F61.
33. Peltola, H., O. P. Heinonen, M. Valle, M. Paunio, M. Virtanen, V. Karanko, and K. Cantell. 1994. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N. Engl. J. Med. 331:1397-1402.
34. Preblud, S. R., W. A. Orenstein, and K. J. Bart. 1984. Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr. Infect. Dis. 3:505-509.
35. Quinlivan, M., K. Hawrami, W. Barrett-Muir, P. Aaby, A. Arvin, V. T. Chow, T. J. John, P. Matondo, M. Peiris, A. Poulsen, M. Siqueira, M. Takahashi, Y. Talukder, K. Yamanishi, M. Leedham-Green, F. T. Scott, S. L. Thomas, and J. Breuer. 2002. The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J. Infect. Dis. 186:888-894.
36. Takayama, M., N. Takayama, N. Inoue, and Y. Kameoka. 1996. Application of long PCR method of identification of variations in nucleotide sequences among varicella-zoster virus isolates. J. Clin. Microbiol. 34:2869-2874.
37. Wagenaar, T. R., C. Grose, V. N. Loparev, D. S. Schmid, and J. Breuer. 2003. Genomic analysis of varicella-zoster virus: primers for individual open reading frames. J. Clin. Virol. 28:104-110.